Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11060-011-0681-7.

Title:
Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma | Journal of Neuro-Oncology
Description:
The purpose of this study is to evaluate the efficacy and toxicity of radiation therapy (RT) with concurrent temozolomide (TMZ) chemotherapy followed by adjuvant TMZ in children with diffuse intrinsic pontine glioma (DIPG). Newly diagnosed patients younger than 18 years with histologically proven DIPG were treated with focal radiotherapy to a dose of 54 Gy in 30 fractions along with concurrent daily TMZ (75 mg/m2/day). Four weeks after completing the initial RT–TMZ schedule, adjuvant TMZ (200 mg/m2/day, days 1–5) was given every 28 days up to six cycles. Responses/progressions were assessed by clinical and 2-monthly MRI follow-up studies. Between September 2005 and September 2009, 21 patients with newly diagnosed histologically confirmed DIPG were eligible for this study. Median age at diagnosis was 6.4 years (range 4–16 years). At last update in August 2010, 17 children have died, 1 child was alive with progressive disease and 3 with stable disease. Metastatic relapse was documented in the cerebral site in two patients and in spinal cord in two cases. The median time to progression was 7.5 months (range 28 days–14.5 months) and the median survival was 11.7 months (range 26 days–17.5 months). The 1-year PFS and the 1-year OS were 33 and 50%, respectively. Five patients presented radiological findings compatible with pseudoprogression during the treatment. Haematological toxicity (Grade III/IV thrombocytopenia and leucopenia) was the most commonly found and led to dose reductions of TMZ in 58% of the patients. TMZ with radiation therapy has not yielded any significant improvement in outcome of children with DIPG and is associated with higher toxicity compared with radiotherapy alone. Novel treatment modalities are needed to improve the outcome of these patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, google, scholar, pubmed, children, cas, diffuse, gliomas, radiotherapy, pontine, study, cancer, temozolomide, glioma, oncol, newly, diagnosed, intrinsic, radiation, brain, treatment, oncology, stem, hyperfractionated, group, therapy, patients, pediatric, brainstem, adjuvant, int, radiat, biol, phys, phase, tmz, department, france, privacy, cookies, content, journal, concurrent, access, trial, results, iii, publish, search, clinical,

Topics {✒️}

month download article/chapter grade iii/iv thrombocytopenia diffuse pontine glioma diffuse brainstem glioma pediatric oncology group pediatric pontine gliomas high-grade malignant gliomas brain-stem glioma diffuse pontine gliomas diffuse brainstem gliomas paediatric oncology brain stem gliomas diffuse pontine lesions brain stem tumors initial rt–tmz schedule full article pdf related subjects privacy choices/manage cookies neuro-oncology aims brazilian cooperative study phase ii study hyperfractionated radiation therapy christelle dufour oncology group prospective observational study histologically proven dipg hospital sainte-anne pediatric gliomas paediatric radiation oncology european economic area marie anne raquin 75 mg/m2/day 200 mg/m2/day 2-monthly mri follow tumours central nervous system institute gustave roussy brain stem article chassot conditions privacy policy high dose busulfan high-dose tamoxifen oral alkylating agent article journal pre-irradiation chemotherapy accepting optional cookies stephanie puget thomas roujeau laura negretti

Questions {❓}

  • Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma
         description:The purpose of this study is to evaluate the efficacy and toxicity of radiation therapy (RT) with concurrent temozolomide (TMZ) chemotherapy followed by adjuvant TMZ in children with diffuse intrinsic pontine glioma (DIPG). Newly diagnosed patients younger than 18 years with histologically proven DIPG were treated with focal radiotherapy to a dose of 54 Gy in 30 fractions along with concurrent daily TMZ (75 mg/m2/day). Four weeks after completing the initial RT–TMZ schedule, adjuvant TMZ (200 mg/m2/day, days 1–5) was given every 28 days up to six cycles. Responses/progressions were assessed by clinical and 2-monthly MRI follow-up studies. Between September 2005 and September 2009, 21 patients with newly diagnosed histologically confirmed DIPG were eligible for this study. Median age at diagnosis was 6.4 years (range 4–16 years). At last update in August 2010, 17 children have died, 1 child was alive with progressive disease and 3 with stable disease. Metastatic relapse was documented in the cerebral site in two patients and in spinal cord in two cases. The median time to progression was 7.5 months (range 28 days–14.5 months) and the median survival was 11.7 months (range 26 days–17.5 months). The 1-year PFS and the 1-year OS were 33 and 50%, respectively. Five patients presented radiological findings compatible with pseudoprogression during the treatment. Haematological toxicity (Grade III/IV thrombocytopenia and leucopenia) was the most commonly found and led to dose reductions of TMZ in 58% of the patients. TMZ with radiation therapy has not yielded any significant improvement in outcome of children with DIPG and is associated with higher toxicity compared with radiotherapy alone. Novel treatment modalities are needed to improve the outcome of these patients.
         datePublished:2011-08-20T00:00:00Z
         dateModified:2011-08-20T00:00:00Z
         pageStart:399
         pageEnd:407
         sameAs:https://doi.org/10.1007/s11060-011-0681-7
         keywords:
            Brainstem glioma
            Child
            Radiation therapy
            Temozolomide
            Oncology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig4_HTML.jpg
         isPartOf:
            name:Journal of Neuro-Oncology
            issn:
               1573-7373
               0167-594X
            volumeNumber:106
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andrea Chassot
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sandra Canale
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Radiology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pascale Varlet
               affiliation:
                     name:Hospital Sainte-Anne
                     address:
                        name:Department of Pathology, Hospital Sainte-Anne, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephanie Puget
               affiliation:
                     name:Hospital Necker Enfants Malades
                     address:
                        name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Roujeau
               affiliation:
                     name:Hospital Necker Enfants Malades
                     address:
                        name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura Negretti
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frederic Dhermain
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xavier Rialland
               affiliation:
                     name:CHU d’Angers
                     address:
                        name:Department of Paediatric Oncology, CHU d’Angers, Angers, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marie Anne Raquin
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jacques Grill
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christelle Dufour
               affiliation:
                     name:Institute Gustave Roussy
                     address:
                        name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma
      description:The purpose of this study is to evaluate the efficacy and toxicity of radiation therapy (RT) with concurrent temozolomide (TMZ) chemotherapy followed by adjuvant TMZ in children with diffuse intrinsic pontine glioma (DIPG). Newly diagnosed patients younger than 18 years with histologically proven DIPG were treated with focal radiotherapy to a dose of 54 Gy in 30 fractions along with concurrent daily TMZ (75 mg/m2/day). Four weeks after completing the initial RT–TMZ schedule, adjuvant TMZ (200 mg/m2/day, days 1–5) was given every 28 days up to six cycles. Responses/progressions were assessed by clinical and 2-monthly MRI follow-up studies. Between September 2005 and September 2009, 21 patients with newly diagnosed histologically confirmed DIPG were eligible for this study. Median age at diagnosis was 6.4 years (range 4–16 years). At last update in August 2010, 17 children have died, 1 child was alive with progressive disease and 3 with stable disease. Metastatic relapse was documented in the cerebral site in two patients and in spinal cord in two cases. The median time to progression was 7.5 months (range 28 days–14.5 months) and the median survival was 11.7 months (range 26 days–17.5 months). The 1-year PFS and the 1-year OS were 33 and 50%, respectively. Five patients presented radiological findings compatible with pseudoprogression during the treatment. Haematological toxicity (Grade III/IV thrombocytopenia and leucopenia) was the most commonly found and led to dose reductions of TMZ in 58% of the patients. TMZ with radiation therapy has not yielded any significant improvement in outcome of children with DIPG and is associated with higher toxicity compared with radiotherapy alone. Novel treatment modalities are needed to improve the outcome of these patients.
      datePublished:2011-08-20T00:00:00Z
      dateModified:2011-08-20T00:00:00Z
      pageStart:399
      pageEnd:407
      sameAs:https://doi.org/10.1007/s11060-011-0681-7
      keywords:
         Brainstem glioma
         Child
         Radiation therapy
         Temozolomide
         Oncology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-011-0681-7/MediaObjects/11060_2011_681_Fig4_HTML.jpg
      isPartOf:
         name:Journal of Neuro-Oncology
         issn:
            1573-7373
            0167-594X
         volumeNumber:106
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andrea Chassot
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sandra Canale
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Radiology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pascale Varlet
            affiliation:
                  name:Hospital Sainte-Anne
                  address:
                     name:Department of Pathology, Hospital Sainte-Anne, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephanie Puget
            affiliation:
                  name:Hospital Necker Enfants Malades
                  address:
                     name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Roujeau
            affiliation:
                  name:Hospital Necker Enfants Malades
                  address:
                     name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura Negretti
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frederic Dhermain
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xavier Rialland
            affiliation:
                  name:CHU d’Angers
                  address:
                     name:Department of Paediatric Oncology, CHU d’Angers, Angers, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marie Anne Raquin
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jacques Grill
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christelle Dufour
            affiliation:
                  name:Institute Gustave Roussy
                  address:
                     name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuro-Oncology
      issn:
         1573-7373
         0167-594X
      volumeNumber:106
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute Gustave Roussy
      address:
         name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Radiology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:Hospital Sainte-Anne
      address:
         name:Department of Pathology, Hospital Sainte-Anne, Paris, France
         type:PostalAddress
      name:Hospital Necker Enfants Malades
      address:
         name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
         type:PostalAddress
      name:Hospital Necker Enfants Malades
      address:
         name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:CHU d’Angers
      address:
         name:Department of Paediatric Oncology, CHU d’Angers, Angers, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
      name:Institute Gustave Roussy
      address:
         name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andrea Chassot
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Sandra Canale
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Radiology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Pascale Varlet
      affiliation:
            name:Hospital Sainte-Anne
            address:
               name:Department of Pathology, Hospital Sainte-Anne, Paris, France
               type:PostalAddress
            type:Organization
      name:Stephanie Puget
      affiliation:
            name:Hospital Necker Enfants Malades
            address:
               name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
               type:PostalAddress
            type:Organization
      name:Thomas Roujeau
      affiliation:
            name:Hospital Necker Enfants Malades
            address:
               name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
               type:PostalAddress
            type:Organization
      name:Laura Negretti
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Frederic Dhermain
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Xavier Rialland
      affiliation:
            name:CHU d’Angers
            address:
               name:Department of Paediatric Oncology, CHU d’Angers, Angers, France
               type:PostalAddress
            type:Organization
      name:Marie Anne Raquin
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Jacques Grill
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      name:Christelle Dufour
      affiliation:
            name:Institute Gustave Roussy
            address:
               name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
      name:Department of Radiology, Institute Gustave Roussy, Villejuif, France
      name:Department of Pathology, Hospital Sainte-Anne, Paris, France
      name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
      name:Department of Neurosurgery, Hospital Necker Enfants Malades, Paris, France
      name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
      name:Department of Radiation Oncology, Institute Gustave Roussy, Villejuif, France
      name:Department of Paediatric Oncology, CHU d’Angers, Angers, France
      name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
      name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
      name:Department of Paediatric and Adolescent Oncology, Institute Gustave Roussy, Villejuif, France
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(129)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.59s.